A quick peek into the report
Table of Contents
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Overview
1.3 Industry Outlook
1.3.1 Regulatory and Legal Requirements and Framework
1.3.1.1 Regulatory and Legal Requirements and Framework in Asia-Pacific
1.3.1.1.1 China
1.3.1.1.2 Japan
1.3.2 Patent Analysis
1.3.2.1 Patent Filing Trend (by Year)
1.3.2.2 Patent Filing Trend (by Country)
1.3.3 Key Trends
1.3.3.1 Nanoparticle-Based Contrast Agents
1.3.3.2 Development of Safer Contrast Media Agent
1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
1.4.1 Pre-COVID-19 Impact
1.4.2 During COVID-19 Impact
1.4.3 Post-COVID-19 Impact
1.5 Market Dynamics
1.5.1 Impact Analysis
1.5.2 Market Drivers
1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
1.5.2.3 Growing Number of Regulatory Approvals
1.5.3 Market Restraints
1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
1.5.4 Market Opportunities
1.5.4.1 IT Advances in Contrast Media Injectors
2.1 Overview
2.2 Asia-Pacific
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.2.1 Impact Analysis
2.2.3 Market Size and Forecast
2.2.3.1 Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
2.2.3.1.1 Asia-Pacific Contrast Media Injector System Market (by Product)
2.2.3.2 Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
2.2.3.2.1 China
2.2.3.2.1.1 Market Sizing and Forecast
2.2.3.2.1.1.1 China Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.1.1.1.1 China Contrast Media Injector System Market (by Product)
2.2.3.2.2 Japan
2.2.3.2.2.1 Market Sizing and Forecast
2.2.3.2.2.1.1 Japan Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.2.1.1.1 Japan Contrast Media Injector System Market (by Product)
2.2.3.2.3 India
2.2.3.2.3.1 Market Sizing and Forecast
2.2.3.2.3.1.1 India Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.3.1.1.1 India Contrast Media Injector System Market (by Product)
2.2.3.2.4 Australia
2.2.3.2.4.1 Market Sizing and Forecast
2.2.3.2.4.1.1 Australia Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.4.1.1.1 Australia Contrast Media Injector System Market (by Product)
2.2.3.2.5 Rest-of-Asia-Pacific
2.2.3.2.5.1 Market Sizing and Forecast
2.2.3.2.5.1.1 Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
2.2.3.2.5.1.1.1 Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)
3.1 Competitive Benchmarking
3.1.1 Key Strategies and Development
3.1.1.1 Regulatory and Legal Activities
3.1.1.2 Partnerships, Collaborations, and Business Expansions
3.1.1.3 Mergers and Acquisitions
3.1.1.4 New Offerings
3.1.2 Market Share Analysis
3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
3.2 Contrast Media Ecosystem Active Players
3.3 Company Profiles
3.3.1 Beijing Beilu Pharmaceutical Co. Ltd.
3.3.1.1 Company Overview
3.3.1.2 Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
3.3.1.3 Recent Developments
3.3.1.4 Analyst Perception
3.3.2 FUJIFILM Holdings Corporation
3.3.2.1 Company Overview
3.3.2.2 Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
3.3.2.3 Financials
3.3.2.4 Analyst Perception
3.3.3 Jiangsu Hengrui Pharmaceutical Co., Ltd.
3.3.3.1 Company Overview
3.3.3.2 Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
3.3.3.3 Recent Developments
3.3.3.4 Analyst Perception
3.3.4 Jodas Expoim Pvt. Ltd.
3.3.4.1 Company Overview
3.3.4.2 Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
3.3.4.3 Analyst Perception
3.3.5 Shenzen Seacrown Electromechanical Co., Ltd.
3.3.5.1 Company Overview
3.3.5.2 Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
3.3.5.3 Recent Developments
3.3.5.4 Analyst Perception
3.3.6 Sino Medical-Device Technology Co., Ltd.
3.3.6.1 Company Overview
3.3.6.2 Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
3.3.6.3 Analyst Perception
3.3.7 Unijules Life Sciences Ltd.
3.3.7.1 Company Overview
3.3.7.2 Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
3.3.7.3 Analyst Perception
Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
Table 2: Key Questions Answered in the Report
Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
Table 5: Some of the Contrast Media Reactions and Effects
Table 6: Guidelines for Contrast Administration and Hydration
Table 7: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
Table 8: Contrast Media Ecosystem Active Players
Figure 1: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 3: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
Figure 4: Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
Figure 5: Contrast Media Agent and Injector System Market: Research Methodology
Figure 6: Primary Research Methodology
Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
Figure 8: Top-Down Approach (Segment-Wise Analysis)
Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
Figure 10: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
Figure 11: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
Figure 12: Contrast Media Agent and Injector System Market, Impact Analysis
Figure 13: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
Figure 14: Incidence of Cardiovascular Disease, 2015 – 2019, Million
Figure 15: Innovative Vendors Product Solutions
Figure 16: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
Figure 17: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 18: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 19: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 20: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
Figure 21: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 22: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 23: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 24: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 25: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 26: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 27: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 28: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 29: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 30: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 31: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 32: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 33: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
Figure 34: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
Figure 35: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
Figure 36: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
Figure 37: Regulatory and Legal Activities, January 2018-May 2023
Figure 38: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
Figure 39: Mergers and Acquisitions, January 2018-May 2023
Figure 40: New Offerings, January 2018-May 2023
Figure 41: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
Figure 42: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
Figure 43: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
Figure 44: FUJIFILM Holdings Corporation: Overall Product Portfolio
Figure 45: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
Figure 46: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 47: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 48: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
Figure 49: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
Figure 50: Jodas Expoim Pvt. Ltd.: Product Portfolio
Figure 51: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
Figure 52: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
Figure 53: Unijules Life Sciences Ltd.: Product Portfolio
Asia-Pacific Contrast Media Agent and Injector System Market Report Coverage:
|
Asia-Pacific Contrast Media Agent and Injector System Market |
|||
|
Base Year |
2022 |
Market Size in 2022 |
$1.98 Billion |
|
Forecast Period |
2022-2026 |
Value Projection and Estimation by 2026 |
$2.62 Billion |
|
CAGR During Forecast Period |
7.24% |
|
|
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.
Key Companies Profiled
• Beijing Beilu Pharmaceutical Co. Ltd.
• FUJIFILM Holdings Corporation
• Jiangsu Hengrui Pharmaceutical Co., Ltd.
• Jodas Expoim Pvt. Ltd.
• Shenzen Seacrown Electromechanical Co., Ltd.
• Sino Medical-Device Technology Co., Ltd.
• Unijules Life Sciences Ltd.
How can this report add value to an organization?
Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.
Introduction to Asia-Pacific Contrast Media Agent and Injector System Market:
The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.
Market Introduction
The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.
Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.
Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.
Market Segmentation:
Segmentation 1: by Product
• Contrast Media Agents
• Injector Systems
Segmentation: Injector Systems (by Product)
• Injector
• Consumables and Accessories
Segmentation 2: by Country
• China
• Japan
• India
• Australia
• Rest-of-Asia-Pacific
Asia-Pacific Contrast Media Agent and Injector System Market
Analysis and Forecast, 2022-2026
Frequently Asked Questions
Contrast media agents, also known as contrast agents or dyes, are chemical compounds used in a range of medical imaging methods, including X-Ray, magnetic resonance imaging (MRI), computed tomography (CT), angiography, and sometimes ultrasound imaging.
Contrast media injectors are medical devices employed to deliver contrast media into the body, improving the visibility of tissues during medical imaging examinations. These devices have evolved from manual injectors to automated systems due to technological advancements over time.
Some key trends in the market for contrast media agents and injector systems include advancements in the safety of contrast agents, with nanoparticles (NPs) showing promise for non-invasive diagnostics. Additionally, collaborations and business partnerships among industry players are on the rise to establish a solid presence in various regions.
Pharmaceutical companies involved in the manufacturing and commercializing of drugs and medical device companies manufacturing injector systems should buy this report.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.